𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tamoxifen beyond 5 years—patients' decisions regarding entry to the aTTom trial

✍ Scribed by M.J Ferguson; J.A Dewar

Book ID
117659033
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
73 KB
Volume
38
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized adjuvant trial to evaluate th
Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer: 5-year results from the nishi-nippon group of the adjuvant chemoendocrine therapy for breast cancer organization
✍ Masakazu Toil; Takao Hattori; Masanobu Akagi; Kiyoshi Lnokuchi; Kunzo Orita; Kei 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB

Background. A randomized adjuvant trial was conducted from October 1982 to January 1985 to evaluate the addition of tamoxifen (TAM) to combination chemotherapy with perioperative mitomycin C (MMC) and ftorafur (FT) for patients with estrogen receptor (ER)-positive tumors and the addition of PSK, a b